A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex.

MLA

Eastwood, Matthew C., et al. “A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 11, no. 4, Apr. 2023, p. 1233. EBSCOhost, https://doi.org/10.1016/j.jaip.2022.12.019.

APA

Eastwood, M. C., Busby, J., Jackson, D. J., Pavord, I. D., Hanratty, C. E., Djukanovic, R., Woodcock, A., Walker, S., Hardman, T. C., Arron, J. R., Choy, D. F., Bradding, P., Brightling, C. E., Chaudhuri, R., Cowan, D., Mansur, A. H., Fowler, S. J., Howarth, P., Lordan, J., … Heaney, L. G. (2023). A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex. The Journal of Allergy and Clinical Immunology. In Practice, 11(4), 1233. https://doi.org/10.1016/j.jaip.2022.12.019

Chicago

Eastwood, Matthew C, John Busby, David J Jackson, Ian D Pavord, Catherine E Hanratty, Ratko Djukanovic, Ashley Woodcock, et al. 2023. “A Randomized Trial of a Composite T2-Biomarker Strategy Adjusting Corticosteroid Treatment in Severe Asthma: A Post Hoc Analysis by Sex.” The Journal of Allergy and Clinical Immunology. In Practice 11 (4): 1233. doi:10.1016/j.jaip.2022.12.019.